Investors are looking forward to second-half 2015 manufacturing results from Solazyme, but it’s important to maintain realistic expectations in other areas of the business, too.
Investors are looking forward to second-half 2015 manufacturing results from Solazyme, but it’s important to maintain realistic expectations in other areas of the business, too.